|
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function …
PR Newswire (press release) HOUSTON, Feb. 21, 2015 /PRNewswire/ — Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat® inhaler from five Phase III trials from the UniTinA-asthma® program at the 2015 American Academy of Allergy, … |
View full post on asthma – Google News